Federal contract award
75N93024P01169
MUCOSAL ADENOVIRUS VACCINE BOOSTING DURABLY PREVENTS XBB.1.16 INFECTION IN NONHUMAN PRIMATES BY IGA
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 513199 — All Other Publishers |
| PSC | T099 — Other Photographic, Mapping, Printing, and Publication Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $12.3K |
| Current contract value | $12.3K |
| Potential contract value / ceiling | $12.3K |
| Start date | Sep 17, 2024 |
| Current end date | Oct 17, 2025 |
| Potential end date | Oct 17, 2025 |
| Latest award activity | Sep 18, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 18, 2024 | 0 | $12.3K | MUCOSAL ADENOVIRUS VACCINE BOOSTING DURABLY PREVENTS XBB.1.16 INFECTION IN NONHUMAN PRIMATES BY IGA |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.